LATE DIAGNOSIS OF MUCOPOLYSACCHARIDOSIS TYPE IV (MAROTEAUX–LAMY SYNDROME)

Author:

Mikhailova L. K.1,Polyakova O. A.1,Zakharova E. Yu.2,Voskoboeva E. Yu.2,Kuleshov A. A.1,Vetrile M. S.1,Lisyanskiy I. N.1

Affiliation:

1. N.N. Priorov National Medical Research Center of Traumatology and Orthopaedics

2. Research Centre of Medical Genetics, Moscow

Abstract

Peculiarities of the clinical manifestation of mucopolysaccharidosis type IV diagnosed at the age of 30 years only are presented. In spite of favorable disease course after the age of 30 years combined vertebral canal stenosis more marked at C0-C1 level, cervical myelopathy and spastic tetraparesis that required surgical intervention. Special attention was paid to the genetic aspects of diagnosis and potential causes of delayed disease development. 

Publisher

ECO-Vector LLC

Subject

General Medicine

Reference23 articles.

1. Novikov P.V. Legal issues relating to rare (orphan) diseases – russian and international experience. Medicine. 2013; 4: 53-73 (in Russian)

2. Novikov P.V., Semyachkina A.N., Voinova V.Yu., et al. Federal clinical recommendations on diagnosis and treatment of mucopolysaccharidosis IV. Moscow; 2013: 22 (in Russian)

3. Harmatz P., Giugliani R., Schwartz I. et al. Enzyme replacement therapy for mucopolysaccharidosis VI: a Phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human Nacetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study. J. Pediatr. 2006; 148: 533-9.

4. Pisaryuk A.S., Lazarev P.V., Lobzhanidze T.V., Shavarov A.A. Mucopolysaccharidosis VI: multiple visceral involvement and the treatment with Naglazyme. Klinicheskaya farmakologiya i terapiya. 2014; 23 (3): 76- 81 (in Russian)

5. Mikhailova L.K., Nechvolodova O.L., Kolesov S.V., et al. Study of mucopolysaccharidosis at CITO. In: Proc. All-Rus. Scient. Pract. Conf. “Priorov’s readings” and Conf. Young Scientists. Moscow, 2015: 110-3 (in Russian)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3